Paying for Care

Understanding the economic impact of health interventions is critical for developing effective programs that can be replicated in different settings. At the 13th Annual Conference on the Science of Dissemination and Implementation in Health, experts shared their top tips about evaluating the economics of a new or existing initiative.

This month’s “Read on Washington,” available only to AcademyHealth members, includes updates on appropriations bills, negotiations to expand Medicare, an executive order to combat drug and medical prices, VA mandates for COVID-19 vaccines, and more.

AcademyHealth Director Lauren Gerlach and Mona Shah of the Robert Wood Johnson Foundation discuss the importance of rigorous evaluation of Section 1115 Medicaid demonstration waivers.

In a recent webinar in collaboration with the National Pharmaceutical Council, experts discussed how to evaluate SDOH programs and interventions from a cost perspective. Speakers emphasized the incomplete state of current knowledge and the need to improve studies and data infrastructure to determine their value.

The Commonwealth Fund Task Force on Payment and Delivery System Reform identified policy interventions for making the U.S. health care delivery system more affordable, equitable and higher quality.

As partners in the Going Below The Surface Forum, AcademyHealth and the National Pharmaceutical Council (NPC) consider the drivers of health spending in the United States through salons focused on challenging questions – which may not have immediate or universally accepted answers – as we attempt to push the conversation beyond the usual stakeholder posturing.